競爭分析:癌症疫苗 是由出版商La Merie Publishing在2011年11月所出版的。
這份英文市場調查報告書價格從美金964起跳。
本報告提供癌症的預防及治療用疫苗的相關調查，彙整研究開發中的目前進展中企劃概要，各競爭企業的趨勢等資料，為您概述為以下內容。
- 胜疫苗
- 蛋白質疫苗
- 抗體疫苗
- DNA(質體或病毒載體等)疫苗
- RNA疫苗
- 類病毒顆粒(VLP)疫苗
- 樹突狀細胞疫苗
- 癌細胞或癌細胞株疫苗
- 佐劑
- 其他
- 各企業癌症疫苗研究開發平台
Abstract
Description
The present Competitive Intelligence report about Cancer Vaccines provides a
competitor evaluation in the field of novel prophylactic and therapeutic
vaccines against cancer. Purchase of the downloadable pdf report includes a
6-month online access to the data of the report and any updates since the
publication date. Credentials to access the database will be sent by e-mail
and allow online work with the project data to print or export an individual
report.
Projects are listed according to their main antigenic constituents: peptides,
recombinant proteins, antibody, DNA (plasmid, expression vector), RNA,
virus-like particles (VLP), dendritic cells, tumor cells (tumor cell lines)
and others.
The report includes a compilation of currently active projects in research and
development for prophylaxis and therapy of cancer. In addition, the report
lists company-specific R&D pipelines of cancer vaccines.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information
about the pipeline of R&D projects for targets, diseases, technologies and
companies at low prices. The information is provided in a tabular format and
fully referenced.
About La Merie
The consultancy business of La Merie Business Intelligence was established in
2002 by Ulrich Martin, MD. Based on his extensive experience in the
biopharmaceutical industry both as a physician specializing in pharmacology
and as a co-founder and CEO of a product development biotech company, La Merie
provides expert consultancy services in R&D, Competitive Intelligence and in
Licensing to the biopharmaceutical industry. The team of La Merie SL currently
consists of six collaborators responsible for R&D, Science, Business
Development, Publishing, eCommerce, Webmastering and IT.
Report Statistics
- Release Date: November of 2011
- Total Number of Pages: 151
- Product Line: Competitor Analysis
- Format: PDF
Table of Contents
- Peptide vaccine
- Protein vaccine
- Antibody vaccine
- DNA (plasmid, viral vector etc) vaccine
- RNA vaccine
- Virus-like particles (VLP) vaccine
- Dendritic cells vaccine
- Tumor cells or tumor cell lines vaccine
- Adjuvants for cancer vaccines
- Others
- Corporate Cacner Vaccine R&D Pipelines
